Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Imago BioSciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Imago BioSciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Henner Dennis | Director | 0 | Jan 11, 2023 | 0 |
| Baltera Robert Jr. | Director | 0 | Jan 11, 2023 | 0 |
| Keating Laurie | Director | – | Jan 11, 2023 | 0 |
| Arenberg Michael | See Remarks | 0 | Jan 11, 2023 | 0 |
| Chaya Moghrabi Dina | Director | – | Jan 11, 2023 | 0 |
| Kariuki Enoch | Director | – | Jan 11, 2023 | 0 |
| Peppe Jennifer | See Remarks | 0 | Jan 11, 2023 | 0 |
| Eichorn Laura G. | Chief Financial Officer | 0 | Jan 11, 2023 | 0 |
| Tapper Amy E. | Chief, Technical Operations | 0 | Jan 11, 2023 | 0 |
| Rienhoff Hugh JR | Chief Executive Officer | 0 | Jan 11, 2023 | 0 |
| Chiang Hsiangyi | Senior Vice President, Finance | 0 | Jan 11, 2023 | 0 |
| Hong Wan-Jen | Chief Medical Officer | 1,000 | Jul 20, 2022 | 0 |
| Schwarzman Stephen A | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Blackstone Inc. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Blackstone Group Management L.L.C. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Blackstone Holdings I/II GP L.L.C. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Blackstone Holdings II L.P. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Clarus Lifesciences III, L.P. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Clarus Ventures III GP, L.P. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Blackstone Clarus III L.L.C. | 10% Owner | 2,375,037Indirect | Apr 1, 2022 | 0 |
| Heron Patrick J | Director | 2,312,331Indirect | Jul 20, 2021 | 0 |
| Frazier Healthcare VII, L.P. | 10% Owner | 2,312,331Indirect | Jul 20, 2021 | 0 |
| Frazier Healthcare VII-A, L.P. | 10% Owner | 2,312,331Indirect | Jul 20, 2021 | 0 |
| FHM VII, L.L.C. | 10% Owner | 2,312,331Indirect | Jul 20, 2021 | 0 |
| FHM VII, L.P. | 10% Owner | 2,312,331Indirect | Jul 20, 2021 | 0 |
| Omega Fund VI, L.P. | Other: Former 10% owner | 3,018,737 | Jul 20, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Baltera Robert Jr.Director | PPurchase | +850 | $16.00 | +$13.6K | New position850 after | |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Omega Fund VI, L.P.Other: Former 10% owner | PPurchase | +250.0K | $16.00 | +$4.00M | New position250.0K after | |
| Jul 20, 2021 (view filing)5:54 PM ET | Jul 20 | Same day | Heron Patrick J and 4 othersDirector | PPurchase | +187.5K | $16.00 | +$3.00M | New position145.9K after | 2 lots |
| Jul 20, 2021 (view filing)6:05 PM ET | Jul 20 | Same day | Schwarzman Stephen A and 7 others10% Owner | PPurchase | +150.0K | $16.00 | +$2.40M | +4.7%3.38M after | |
| Jan 14, 2022 (view filing) | Jan 12 | 2 days | Eichorn Laura G.See Remarks | SSale | −8.00K | $19.96 | −$159.7K | −3.7%207.7K after | |
| Jan 14, 2022 (view filing) | Jan 12 | 2 days | Tapper Amy E.See Remarks | SSale | −6.00K | $19.96 | −$119.8K | −4.8%119.0K after | |
| Jan 14, 2022 (view filing) | Jan 12 | 2 days | Peppe JenniferSee Remarks | SSale | −14.0K | $19.95 | −$279.3K | −8.6%148.8K after | |
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Tapper Amy E.See Remarks | SSale | −6.50K | $19.76 | −$128.4K | −5.2%119.0K after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Peppe JenniferSee Remarks | SSale | −13.0K | $20.48 | −$266.2K | −8.0%148.8K after | 2 lots |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | Tapper Amy E.See Remarks | SSale | −3.00K | $21.54 | −$64.6K | −2.5%119.0K after | |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | Eichorn Laura G.See Remarks | SSale | −4.00K | $21.56 | −$86.2K | −1.9%207.7K after | |
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | Peppe JenniferSee Remarks | SSale | −10.0K | $22.26 | −$222.6K | −6.3%148.8K after | |
| Feb 15, 2022 (view filing) | Feb 11 | 4 days | Tapper Amy E.See Remarks | SSale | −3.00K | $23.78 | −$71.3K | −2.5%119.0K after | |
| Feb 15, 2022 (view filing) | Feb 11 | 4 days | Eichorn Laura G.See Remarks | SSale | −4.00K | $23.61 | −$94.4K | −1.9%207.7K after | |
| Feb 15, 2022 (view filing) | Feb 11 | 4 days | Peppe JenniferSee Remarks | SSale | −7.00K | $23.76 | −$166.3K | −4.5%148.8K after | |
| Feb 24, 2022 (view filing) | Feb 22 | 2 days | Eichorn Laura G.See Remarks | SSale | −8.00K | $21.60 | −$172.8K | −3.7%207.7K after | 2 lots |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Tapper Amy E.See Remarks | SSale | −750 | $17.90 | −$13.4K | −0.6%119.0K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Eichorn Laura G.See Remarks | SSale | −1.00K | $18.00 | −$18.0K | −0.5%207.7K after | |
| Aug 16, 2022 (view filing) | Aug 12-15 | 4 days | Tapper Amy E.See Remarks | SSale | −12.3K | $19.18 | −$234.9K | −9.3%119.0K after | 2 lots |
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Peppe JenniferSee Remarks | SSale | −5.60K | $19.41 | −$108.7K | −3.6%148.8K after | |
| Aug 17, 2022 (view filing) | Aug 16 | 1 day | Peppe JenniferSee Remarks | SSale | −6.40K | $19.41 | −$124.3K | −4.1%148.8K after | |
| Aug 18, 2022 (view filing) | Aug 16-17 | 2 days | Eichorn Laura G.See Remarks | SSale | −906 | $19.50 | −$17.7K | −0.4%207.7K after | 2 lots |
| Aug 24, 2022 (view filing) | Aug 22 | 2 days | Eichorn Laura G.Chief Financial Officer | SSale | −447 | $18.00 | −$8.05K | −0.2%207.7K after | |
| Nov 4, 2022 (view filing) | Nov 2 | 2 days | Eichorn Laura G.Chief Financial Officer | SSale | −553 | $18.00 | −$9.95K | −0.3%207.7K after | |
| Nov 4, 2022 (view filing) | Nov 2 | 2 days | Tapper Amy E.See Remarks | SSale | −750 | $17.90 | −$13.4K | −0.6%119.0K after | |
| Dec 19, 2022 (view filing) | Dec 15-16 | 4 days | Rienhoff Hugh JRChief Executive Officer | SSale | −473.1K | $35.79 | −$16.9M | −49.1%489.5K after | 2 lots |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Eichorn Laura G.Chief Financial Officer | SSale | −126.7K | $35.79 | −$4.54M | −37.9%207.7K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Peppe JenniferSee Remarks | SSale | −119.4K | $35.80 | −$4.28M | −44.5%148.8K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Peppe JenniferSee Remarks | SSale | −119.4K | $35.80 | −$4.28M | −44.5%148.8K after | Duplicate filing |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Arenberg MichaelSee Remarks | SSale | −47.8K | $35.78 | −$1.71M | −65.7%24.9K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Tapper Amy E.See Remarks | SSale | −100.3K | $35.78 | −$3.59M | −45.7%119.0K after | |
| Dec 29, 2022 (view filing) | Dec 27 | 2 days | Arenberg MichaelSee Remarks | SSale | −70.5K | $35.93 | −$2.53M | −58.8%49.4K after | |
| Dec 29, 2022 (view filing) | Dec 27 | 2 days | Eichorn Laura G.Chief Financial Officer | SSale | −3.10K | $35.93 | −$111.4K | −1.5%207.7K after |